In this episode of MEC Connect Impact Stories, Jeff Pack Medical Management Consultant at MEC, shares two compelling cases that highlight how proactive clinical oversight and disciplined cost management can significantly reduce medical spend without impacting the quality of care for injured workers.

Jeff explores a rare and complex COVID‑19 vaccine–related claim involving immune thrombocytopenic purpura (ITP), where ongoing high‑cost specialty pharmacy treatments required close monitoring and strategic vendor negotiation. By collaborating with a preferred bill review vendor, MEC achieved meaningful cost reductions while maintaining treatment stability for the injured worker.

He then reviews a traumatic brain injury case where prescription refill patterns revealed an opportunity to adjust medication formulation — preserving therapeutic effectiveness while dramatically lowering long‑term pharmacy costs. By engaging defense counsel and the treating provider, the MEC team implemented a safe, physician‑approved change that resulted in substantial lifetime savings.

These Impact Stories demonstrate how MEC’s experienced people, proven processes, and trusted vendor relationships work together to deliver results that matter — protecting injured workers’ outcomes while responsibly managing catastrophic claim costs. 

Send us a text and let us know what you think!